About

Dr. Richard Bradlow

FRANZCP (Cert. Addictions), MBBS (Hons), MMed (Psychiatry), MSc (Addiction Studies)

Dr Bradlow sees general psychiatry and addiction psychiatry patients privately and publicly. Privately, he is available at the Victoria Clinic where he runs the inpatient withdrawal service and consults to outpatients. Publicly, he consults at the Austin Hospital.

Dr Bradlow studied undergraduate medicine at Monash University, holds two separate masters degrees, in psychiatry and in addiction, and is currently completing a PhD through the University of Melbourne.

He has an interest in education and teaches the psychopharmacology unit at Monash University’s Master of Mental Health Science, is a clinical supervisor to psychiatry trainees, and co-hosts a weekly podcast on addiction.

Dr Bradlow completed his advanced training in addiction at Turning Point - the state’s premier drug and alcohol service. He has a keen interest in research and contributes to scientific literature frequently, having been published in multiple academic journals.

Dr Bradlow welcomes all patients aged 18-65

Dr Rich's profiles at:

Schizoaffective disorder
Functional neurologial disorders
Somatic neurological disorders
Motivational interviewing
Young mental health
Gender and sexual diversity mental health

Areas of expertise

Addiction
Anxiety disorders
Depression
Borderline personality disorder
Trauma
Post-traumatic stress disorder
Bipolar disorder
Schizophrenia

Schizoaffective disorder
Functional neurological disorders
Somatic symptom disorders
Motivational interviewing
Youth mental health
Gender and sexual diversity mental health

To book in to see Dr Bradlow, please obtain a referral from your GP then contact The Victoria Clinic on (03) 9526 0244 to make an appointment. You will need an active referral to book and obtain a Medicare rebate.

Research

Swannell, M., Bradlow, R. C., Pham, D., Gabriel, J., Manahan, Y., & Arunogiri, S. (2025). Pharmacological treatments for co-occurring PTSD and substance use disorders: A systematic review. Journal of Substance Use and Addiction Treatment, 169, 209601.

https://doi.org/10.1016/j.josat.2024.209601

Bradlow, R. C., Wright, S., Szrajbman Vaz Da Silva, A., & Armstrong, F. (2024). High Prescribing: A Case Study of High‐Potency Medicinal Cannabis Inducing Psychosis. Case Reports in Psychiatry, 2024(1), 8870476.

https://doi.org/10.1155/crps/8870476

Bradlow, R. C., & Armstrong, F. (2024). Is the current commercial model of medicinal cannabis in the best interest of patients?. Medical Journal of Australia, 220(11), 592-592.

https://doi.org/10.5694/mja2.52313

Bradlow, R. C. J., Meyer, B., & Kanaan, R. (2024) Research Letter: Functional neurological disorder in transgender people: A case series. Australian & New Zealand Journal of Psychiatry.;58(3):277-280. https://doi.org/10.1177/00048674231216358

Bradlow, R.C., Hicks, B., Mu, T., Pham, D., Sharkey, M., Plumley, N., Lubman, D.I. & Arunogiri, S. (2023). Management of opiate dependence related to dihydrocodeine–sorbitol misuse. Medical Journal of Australia, 219(5), 200-201.

https://doi.org/10.5694/mja2.52060

Allebone, J., Wilson, S. J., Bradlow, R. C., Maller, J., O'Brien, T., Mullen, S. A., Cook, M., Adam, S. A., Vogrin, S., Vaughan, D. N., Connelly, A., Kwan, P., Berkovic, S. F., D’Souza, W. J., Jackson, G. Velakoulis, D., & Kanaan, R. A. (2022). Increased cortical thickness in nodes of the cognitive control and default mode networks in psychosis of epilepsy. Seizure, 101, 244-252. https://doi.org/10.1016/j.seizure.2022.09.006

Bradlow, R.C.J., Berk, M., Kalivas, P.W., Back, S. E., & Kanaan R. A. (2022). The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs, 36(5), 451–482.

https://doi.org/10.1007/s40263-022-00907-3

Bradlow, R., Singh, N., Beloskar, S., & Kalra, G. Gender and sexual minorities. In: Bhugra, D., Ventriglio, A., Castaldelli-Maia, J., & McCay, L. (Eds.). (2019). Urban Mental Health. Oxford University Press. https://doi.org/10.1093/med/9780198804949.003.0018